Are Volumetric Changes of Brain Metastases the Best Evaluation of Efficacy?

only as a secondary end point. There are clearly many unanswered questions about the treatment of brain metastases in women with breast cancer. We believe …

More PDF Content

Correspondence, AUTHORS\’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST, Research Funding, Expert Testimony, Other Remuneration, REFERENCE, Employment or Leadership Position, Consultant or Advisory, Role, Stock Ownership, Honoraria, TO THE EDITOR, 5137, Yazid Belkacemi, 10. Abraham Kuten, 11. 12. 13. REFERENCES, 14. IN REPLY, Nancy U. Lin and Eric P. Winer.
Although all authors completed the disclosure declaration, the following author(s) indicated a financial or other interest that is relevant to the subject matter under consideration in this article. Certain relationships marked with a \”U\” are those for which no compensation was received; those relationships marked with a \”C\” were compensated. For a detailed description of the disclosure categories, or for more information about ASCO\’s conflict of interest policy, please refer to the Author Disclosure Declaration and the Disclosures of Potential Conflicts of Interest section in Information for Contributors. Employment or Leadership Position: None Consultant or Advisory Role: None Stock Ownership: None Honoraria: Kazuyuki Shimada,

Download Are Volumetric Changes of Brain Metastases the Best Evaluation of Efficacy? pdf from jco.ascopubs.org, 2 pages, 60.05KB.